Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Oct 18;22(1):315.
doi: 10.1186/s12936-023-04745-6.

Enhanced effect of seasonal malaria chemoprevention when coupled with nutrients supplementation for preventing malaria in children under 5 years old in Burkina Faso: a randomized open label trial

Affiliations
Randomized Controlled Trial

Enhanced effect of seasonal malaria chemoprevention when coupled with nutrients supplementation for preventing malaria in children under 5 years old in Burkina Faso: a randomized open label trial

Paul Sondo et al. Malar J. .

Abstract

Background: In rural African settings, most of the children under the coverage of Seasonal Malaria Chemoprevention (SMC) are also undernourished at the time of SMC delivery, justifying the need for packaging malarial and nutritional interventions. This study aimed at assessing the impact of SMC by coupling the intervention with nutrients supplementation for preventing malaria in children less than 5 years old in Burkina Faso.

Methods: A randomized trial was carried out between July 2020 and June 2021 in the health district of Nanoro, Burkina Faso. Children (n = 1059) under SMC coverage were randomly assigned to one of the three study arms SMC + Vitamin A (SMC-A, n = 353) or SMC + Vitamin A + Zinc (SMC-AZc, n = 353) or SMC + Vitamin A + PlumpyDoz(tm) (SMC-APd, n = 353)-a medium quantity-lipid-based nutrient supplement (MQ-LNS). Children were followed up for one year that included an active follow-up period of 6 months with scheduled monthly home visits followed by 6 months passive follow-up. At each visit, capillary blood sample was collected for malaria diagnosis by rapid diagnosis test (RDT).

Results: Adding nutritional supplements to SMC had an effect on the incidence of malaria. A reduction of 23% (adjusted IRR = 0.77 (95%CI 0.61-0.97) in the odds of having uncomplicated malaria in SMC-APd arm but not with SMC-AZc arm adjusted IRR = 0.82 (95%CI 0.65-1.04) compare to control arm was observed. A reduction of 52%, adjusted IRR = 0.48 (95%CI 0.23-0.98) in the odds of having severe malaria was observed in SMC-APd arm compared to control arm. Besides the effect on malaria, this combined strategy had an effect on all-cause morbidity. More specifically, a reduction of morbidity odds of 24%, adjusted IRR = 0.76 (95%CI 0.60-0.94) in SMC-APd arm compared to control arm was observed. Unlike clinical episodes, no effect of nutrient supplementation on cross sectional asymptomatic infections was observed.

Conclusion: Adding nutritional supplements to SMC significantly increases the impact of this intervention for preventing children from malaria and other childhood infections.

Trial registration: NCT04238845.

Keywords: Malaria; Malnutrition; PlumpyDoz™; Seasonal chemo-prevention; Vitamin A; Zinc.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Trial profile. Flowchart of the study participant from inclusion to the end of the follow-up period
Fig. 2
Fig. 2
Cumulative incidence of uncomplicated malaria. Number of admissions to the health facilities due to uncomplicated malaria diagnosed clinically and confirmed by RDT per study arm form the beginning of the intervention to the end of the follow-up period. Note that each participant can contribute more than one episode of uncomplicated malaria over the study period. Blue curve represents control arm while green and red curves represent Plumpy’Doz and Zinc arm, respectively
Fig. 3
Fig. 3
Cross-sectional RDT positivity rate per study arm. This figure displays the proportion of participants tested positive for malaria when deploying the RDT. For this, monthly visits data were used to estimate the proportions of infected participants to malaria when using RDT per study arm. Blue curve represents control arm while green and red curves represent Plumpy’Doz and Zinc arm, respectively
Fig. 4
Fig. 4
Cumulative incidence of all cause morbidity over the study period. Number of admissions to the health facilities due to a disease regardless the type of infections per study arm form the beginning of the intervention to the end of the follow-up period. Blue curve represents control arm while green and red curves represent Plumpy’Doz and Zinc arm, respectively. Note that each participant can contribute more than one episode of all cause morbidity over the study period

References

    1. WHO . World malaria report 2022. Geneva: World Health Organization; 2023.
    1. WHO . Policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: World Health Organization; 2012.
    1. ACCESS-SMC Partnership Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. Lancet. 2020;396:1829–40. doi: 10.1016/S0140-6736(20)32227-3. - DOI - PMC - PubMed
    1. Meremikwu MM, Donegan S, Sinclair D, Esu E, Oringanje C. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database Syst Rev. 2012;2:CD003756. - PMC - PubMed
    1. Moukénet A, Donovan L, Honoré B, Baker K, Smith H, Richardson S, et al. Extending delivery of seasonal malaria chemoprevention to children aged 5–10 years in Chad: a mixed-methods study. Glob Health Sci Pract. 2022;10:e2100161. doi: 10.9745/GHSP-D-21-00161. - DOI - PMC - PubMed

Publication types

Associated data